Liposomal prostaglandin formulations

Details Liposomal prostaglandin formulations Liposomal prostaglandin formulations

A - Human Necessities

61

K

A61K 31/557 (2006.01) A61K 9/127 (2006.01) A61K 31/5575 (2006.01)

Patent

CA 2108788

A method of treating a cell activation/adhesion syndrome in mammals, including humans, by the administration of a pros- taglandin associated with a liposome is disclosed. Such cell activation/adhesion syndromes may include reperfusion injury, sep- tic shock, myocardial infarction, adult respiratory distress syndrome, rheumatoid vasculitis, systemic vasculitis, lupus, post trau- matic shock, burn injury or restenosis after angioplasty. In a preferred embodiment, the prostaglandin is encapsulated in the liposomes.

Affiliated with

Also associated with

Rating

Liposomal prostaglandin formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liposomal prostaglandin formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liposomal prostaglandin formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2025853